Stock Taper
SCREENER COMPARE ANY 2 STOCKS
AIMD
AINOS, INC.
NASDAQ
$1.41
▼ DOWN 0.70% (-0.01)

KEY STATISTICS

Market Cap$10.38 M
52w High$4.44
52w Low$1.26
Dividend Yield—
Frequency—
P/E-0.56
Volume10.31K
Shares Out.7.36M

COMPANY

LEADERSHIP

Chun-Hsien Tsai
CHIEF EXECUTIVE
Chun-Hsien Tsai

COMPENSATION 2026

Salary$95,912
Stock Awards$1,172,899
Incentive Plan Pay$0
All Other Comp.$0
Total$1,285,023

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 8, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
41

SPLIT RECORD

DATETYPERATIO
2025-06-30Reverse1:5
2023-12-14Reverse1:5
2022-08-09Reverse1:15
2014-12-17Reverse1:19

PRICE

$1.41 ▼ DOWN 0.70% (−$0.01)
OVERLAYS
$1.38$1.40$1.42$1.449:35 AM10:39 AM11:43 AM12:47 PM1:51 PM2:55 PM3:59 PM1.41

About Ainos, Inc.

https://www.ainos.com ↗

Ainos, Inc. develops medical technologies including rapid COVID-19 tests, cloud-based test management, VOC testing, low-dose oral interferon, and RNA platforms to advance point-of-care healthcare solutions.

INDUSTRY

Biotechnology

A PRODUCT AINOS, INC. IS KNOWN FOR

AI Nose
AI Nose

The AI Nose is a SmellTech platform that digitizes scents into Smell IDs for use in smart manufacturing, robotics, and healthcare, with recent deployments in semiconductor industry monitoring and safety.

ETFS HOLDING THIS STOCK

ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
VXF
0.00% · 16.4K

RATINGS SNAPSHOT

Overall rating: D+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book2
Overall Score1

INSIDER TRADES

★
DIRECTOR
chiang yao-chung
Purchase · 3.5K shares
2026-06-05
★
DIRECTOR
chiang yao-chung
Purchase · 2.0K shares
2026-06-03
★
DIRECTOR
chiang yao-chung
Purchase · 250 shares
2026-05-28
★
DIRECTOR
chiang yao-chung
Purchase · 2.0K shares
2026-05-27

SECTORS PEERS

PEERPRICE
ANL$13.82COMPARE
BLRX$2.60COMPARE
DARE$0.73COMPARE
ICU$3.09COMPARE
ADTX$0.01COMPARE
GOVX$0.72COMPARE
MBRX$0.65COMPARE
FBLG$1.44COMPARE